J05AR Antivirals for treatment of HIV infections, combinations

Place in the ATC system

1. J Antiinfectives for systemic use 1,101 drugs
   1. J05 Antivirals for systemic use 246 drugs
      1. J05A Direct acting antivirals 246 drugs
         1. J05AR Antivirals for treatment of HIV infections, combinations 40 drugs
            1. J05AR01 Zidovudine and lamivudine 5 drugs
            2. J05AR02 Lamivudine and abacavir 9 drugs
            3. J05AR03 Tenofovir disoproxil and emtricitabine 6 drugs
            4. J05AR04 Zidovudine, lamivudine and abacavir 2 drugs
            5. J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz 5 drugs
            6. J05AR08 Emtricitabine, tenofovir disoproxil and rilpivirine 1 drug
            7. J05AR09 Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat 1 drug
            8. J05AR13 Lamivudine, abacavir and dolutegravir 1 drug
            9. J05AR14 Darunavir and cobicistat 1 drug
            10. J05AR15 Atanazavir and cobicistat 1 drug
            11. J05AR17 Emtricitabine and tenofovir alafenamide 1 drug
            12. J05AR18 Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat 1 drug
            13. J05AR19 Emtricitabine, tenofovir alafenamide and rilpivirine 1 drug
            14. J05AR20 Emtricitabine, tenofovir alafenamide and bictegravir 1 drug
            15. J05AR21 Dolutegravir and rilpivirine 1 drug
            16. J05AR22 Emtricitabine, tenofovir alafenamide, darunavir and cobicistat 1 drug
            17. J05AR24 Lamivudine, tenofovir disoproxil and doravirine 1 drug
            18. J05AR25 Lamivudine and dolutegravir 1 drug

Active ingredients of the class

• Abacavir (abacavir sulfate) 12 drugs
• Atazanavir (atazanavir sulfate) 1 drug
• Bictegravir (bictegravir sodium) 1 drug
• Cobicistat 5 drugs
• Darunavir (darunavir ethanolate) 2 drugs
• Dolutegravir (dolutegravir sodium) 3 drugs
• Doravirine 1 drug
• Efavirenz 5 drugs
• Elvitegravir 2 drugs
• Emtricitabine 18 drugs
• Lamivudine 19 drugs
• Rilpivirine (rilpivirine hydrochloride) 3 drugs
• Tenofovir alafenamide (tenofovir alafenamide hemifumarate) 5 drugs
• Tenofovir disoproxil fumarate 14 drugs
• Zidovudine 7 drugs

Drugs in the class and its subclasses

Other classes of the same level

• J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
• J05AD Phosphonic acid derivatives, direct acting antivirals 1 drug
• J05AE Protease inhibitors, direct acting antivirals 28 drugs
• J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
• J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
• J05AH Neuraminidase inhibitors, direct acting antivirals 10 drugs
• J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
• J05AP Antivirals for treatment of HCV infections 16 drugs
• J05AX Other antivirals 13 drugs

Other names of the drug class

• Czech: J05AR Antivirotika k léčbě infekce HIV, kombinace
• English (United Kingdom): J05AR Antivirals for treatment of HIV infections, combinations
• French: J05AR antiviraux utilisés en association pour le traitement des infections à vih
• German: J05AR Antivirale Mittel zur Behandlung von HIV Infektionen, Kombinationen
• German (Austria): J05AR Antivirale Mittel zur Behandlung von HIV Infektionen, Kombinationen
• Italian: J05AR Antivirali per il trattamento dell'infezione da HIV associazioni ( Compatibilmente con le esigenze cliniche del paziente, privilegiare il farmaco con un rapporto costo/efficacia più favorevole)
• Polish: J05AR Leki przeciwwirusowe do leczenia zakażenia HIV, kombinacje
• Turkish: J05AR HIV enfeksiyonlarının tedavisi için antiviraller, kombinasyonlar
• Portuguese (Brazil): J05AR Anti-víricos para o tratamento de infecções por VIH, associações
• German (Switzerland): J05AR Antivirale Mittel zur Behandlung von HIV Infektionen, Kombinationen
• French (Switzerland): J05AR Antiviraux utilisés en association pour le traitement des infections à vih
• Italian (Switzerland): J05AR Antivirali per il trattamento dell'infezione da HIV associazioni ( Compatibilmente con le esigenze cliniche del paziente, privilegiare il farmaco con un rapporto costo/efficacia più favorevole)
• Dutch: J05AR Antivirale middelen voor de behandeling van hiv-infecties, combinaties